2014: We launch the Observia platform to support community pharmacists in their new functions. The project, still actively used by more than 3 800 pharmacies, receives the Janus award.

2015: We start dreaming of a behavioral diagnostic tool to build solutions adapted to everyone.

2016: We create Observia Consulting offering. Our teams grow in France and abroad to manage our first European projects.

2017: We launch SPUR™, our behavioral diagnostic tool, and start building our 4-year research program and board of experts. We receive the prestigious Prix Gallien for our project “Mon Carnet AVK”.

2018: We move to our own offices to welcome our growing teams of experts. Our first global projects led us to Indonesia, Brazil, USA and China, where we open a subsidiary.

2019: Our international footprint widens with new projects in Algeria and a new team in Germany. Iphodia study is published, demonstrating the positive impact of pharmacist advice on T2D patients’ health

2020: We release our first SPUR™ publication validating the robustness of the framework. Despite the COVID pandemics, our research program continues its rollout.

2021: We are 10 years old already! We publish the results of three new studies, of which the results demonstrating SPUR’s validation as a new tool to measure medication non-adherence.

2022: We officially launch SPUR^TM with 6 scientific publications and sign a partnership agreement for its exclusive distribution to researchers worldwide by Mapi Research Trust.

2023: We set course for the future with a clear plan. Keep sharing our convictions, continuing to develop our products, expanding geographically, and generalizing the use of our solutions.